Review of Clinical Pharmacology and Pharmacokinetics – International Edition – Volume 38 (2024) – Supplementary Issue 2

Obesity is a worldwide issue that is progressively worsening. It can result in significant co-morbidities, including type 2 diabetes, cardiovascular disease, and obesity-related cancers. Current treatment options for obesity have several limitations, and the connection between obesity and cancer development is not well comprehended. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition – Volume 38 (2024) – Issue 1

Lutein is a xanthophyll carotenoid that can be found in a divergency of fruits and plants. Its main action is to protecteye health and vision. Its antioxidant properties play a crucial role in eye agitations, in decreasing inflammation, inprotecting the neural tissues from chemical analyzed hypoxia and cell apoptosis. Lutein supplementation inassociation with low-calorie diet had a notable abatement in fat-free mass, visceral fat and serum levels of totalcholesterol and LDL-cholesterol. Lutein may also have a natural anti-cancer effect. This is because foods rich in luteinhave antioxidant activity and oppose inflammation and oxidative stress. The benefits to the literature from this mini-review is that it has summarized the main actions of lutein in the human body. Continue reading

Τόμος 36 (2022) – Τεύχος 1 – Άρθρο 1 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 36 (2022) – Issue 1 – Article 1 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Dietary supplements: Innocent or potentially carcinogenic Continue reading